Portal de Periódicos da CAPES

Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy

2019; Massachusetts Medical Society; Volume: 380; Issue: 24 Linguagem: Inglês

10.1056/nejmc1903064

1533-4406

Khashayar Esfahani, Najwa Buhlaiga, Paméla Thébault, Réjean Lapointe, Nathalie A. Johnson, Wilson H. Miller,

Immune Cell Function and Interaction

Alemtuzumab for Immune-Related Myocarditis Myocarditis after the use of immune checkpoint inhibitors is a potentially fatal complication. Immune suppression with glucocorticoids is often effective ...